CR20120114A - Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico - Google Patents

Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico

Info

Publication number
CR20120114A
CR20120114A CR20120114A CR20120114A CR20120114A CR 20120114 A CR20120114 A CR 20120114A CR 20120114 A CR20120114 A CR 20120114A CR 20120114 A CR20120114 A CR 20120114A CR 20120114 A CR20120114 A CR 20120114A
Authority
CR
Costa Rica
Prior art keywords
glucocorticoid
antimicrobial
combination
antimicótico
composition
Prior art date
Application number
CR20120114A
Other languages
English (en)
Inventor
Salgado Lopez Raul Garcia
Hernadez Gustavo Barranco
Original Assignee
Senosian S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosian S A De C V Lab filed Critical Senosian S A De C V Lab
Publication of CR20120114A publication Critical patent/CR20120114A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica tópica que comprende la combinación de un antimicrobiano, un glucocorticoide, un antimicótico y vehículos o excipientes farmacéuticamente aceptables.
CR20120114A 2009-09-15 2012-03-12 Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico CR20120114A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009009884A MX2009009884A (es) 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.

Publications (1)

Publication Number Publication Date
CR20120114A true CR20120114A (es) 2012-06-08

Family

ID=43759111

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120114A CR20120114A (es) 2009-09-15 2012-03-12 Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico

Country Status (15)

Country Link
US (1) US8895538B2 (es)
EP (1) EP2478908B1 (es)
AR (1) AR078370A1 (es)
BR (1) BR112012005895B8 (es)
CA (1) CA2774356C (es)
CO (1) CO6511242A2 (es)
CR (1) CR20120114A (es)
DO (1) DOP2012000065A (es)
EC (1) ECSP12011727A (es)
ES (1) ES2716505T3 (es)
GT (1) GT201200074A (es)
HN (1) HN2012000527A (es)
MX (1) MX2009009884A (es)
PE (1) PE20121351A1 (es)
WO (1) WO2011033361A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687206A (zh) * 2014-11-27 2016-06-22 四川海思科制药有限公司 一种夫西地酸戊酸倍他米松乳膏药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298604B1 (en) 1980-10-06 1998-12-22 Schering Corp Clotrimazole-betamethasone dipropionate combination
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
MX2010002592A (es) * 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
WO2010106465A1 (en) 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
US20120035144A1 (en) 2009-04-20 2012-02-09 Apex Laboratories Private Limited Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
WO2010122475A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it

Also Published As

Publication number Publication date
ECSP12011727A (es) 2012-04-30
EP2478908A4 (en) 2013-04-03
CA2774356A1 (en) 2011-03-24
WO2011033361A2 (es) 2011-03-24
EP2478908A2 (en) 2012-07-25
BR112012005895B8 (pt) 2021-05-25
BR112012005895A2 (pt) 2017-06-06
CO6511242A2 (es) 2012-08-31
DOP2012000065A (es) 2012-05-31
BR112012005895B1 (pt) 2020-11-24
US8895538B2 (en) 2014-11-25
EP2478908B1 (en) 2018-12-26
CA2774356C (en) 2017-05-30
AR078370A1 (es) 2011-11-02
PE20121351A1 (es) 2012-10-27
ES2716505T3 (es) 2019-06-12
HN2012000527A (es) 2014-09-22
GT201200074A (es) 2014-03-05
WO2011033361A3 (es) 2011-07-21
US20120178727A1 (en) 2012-07-12
MX2009009884A (es) 2011-03-16

Similar Documents

Publication Publication Date Title
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
MX2011011514A (es) Formulaciones de canabidiol y metodos para utilizarlas.
CU20100230A7 (es) Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
BR112012024432A2 (pt) composição farmacêutica de dissolução rápida
MX2013000642A (es) Composiciones farmaceuticas.
AP2012006292A0 (en) Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
PA8846401A1 (es) Sinergismo antibiótico
EA201071412A1 (ru) Дронедарон для предотвращения кардиоверсии
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
ECSP15050273A (es) Formulación oral para el tratamiento de enfermedades cardiovasculares
BR112013000930A2 (pt) formulações de 14-epi-análogos de vitamina d e cmc
CR20120114A (es) Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico
EA201270547A1 (ru) Фармацевтическая композиция
ECSP10010402A (es) ASOCIACIÓN DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE
DOP2013000144A (es) Combinacion y composicion para el tratamiento de obesidad
ECSP13012765A (es) Combinación y composición para el tratamiento de obesidad
DK2285367T3 (da) Farmaceutiske sammensætninger til behandling af vorter
IN2014KN02584A (es)
IN2013MU02015A (es)
UA110091C2 (xx) Хронотерапевтична фармацевтична композиція
CL2010001230A1 (es) Metodo para inhibir la melanogenesis que comprende administrar un compuesto esteroidal; composicin farmaceutica; formulacion topica, util en el tratamiento de una enfermedad o condicion que involucra melanogenesis.
TR201002947A2 (tr) Hemoroit tedavisi için bir bitkisel preparat
UY31650A1 (es) Formulaciones de flibanserina